COMMUNIQUÉS West-GlobeNewswire

Merit Medical Announces Appointment of Lynne N. Ward to Its Board of Directors
19/08/2019
SOUTH JORDAN, Utah, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Exactus Inc. to Sponsor South Florida PGA Senior PGA Professional Championship and Exhibit at Upcoming BIG Industry Show
19/08/2019
DELRAY BEACH, Fla., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI) a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced it is an official sponsor of The [...]
Mateon Enters into Merger Agreement with PointR Data to Leverage Disruptive AI Technology in Its Innovation-Driven Quest for a Cure of Cancer
19/08/2019
AGOURA HILLS, Calif. and SANTA CLARA, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”) and PointR Data Inc. (PointR), a privately-held, developer of high performance cluster [...]
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for First Pediatric-Specific Foot System
19/08/2019
WARSAW, Ind., Aug. 19, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has received [...]
Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50
19/08/2019
Generex Now Owns 99% of Subsidiary Olaregen Therapeutix Generex Satisfies Notes for $138,000 and $900,000 to clear debt NuGenerex Immuno-Oncology Spin-out Evaluating Acquisition of a Hospital Network Completed Audit of [...]
Afya Limited Announces the Appointment of a New Director
19/08/2019
NOVA LIMA, Brazil, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the appointment of Daulins Emilio to its board of directors as a non-independent director, effective as of August [...]
Better Choice Company Appoints Pet Industry Veteran Ian Weiss as Vice President of Sales
19/08/2019
Brings to Bear Nearly Two Decades of Strategic, Sales and Channel Partner Experience in the Pet Industry NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better [...]
Clarus Therapeutics Announces FDA Award of 3-Year Market Exclusivity for Jatenzo®
19/08/2019
JATENZO ® is a first-in-class proprietary softgel oral formulation of testosterone undecanoate for testosterone replacement therapy in certain adult hypogonadal men and the first oral testosterone replacement product of [...]
Yield10 Bioscience Expands Research License with Bayer for Evaluation of a Novel C3004 Yield Trait Gene in Soybean
19/08/2019
WOBURN, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Qrons Selects PCG Advisory for Investor Relations and Strategic Communications as it Advances its Product Candidates
19/08/2019
NEW YORK, NY,, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTCQB: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of [...]
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19/08/2019
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH) is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ) for a world-wide [...]
Novo Nordisk A/S – Share repurchase programme
19/08/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 19 August 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]
Fortress Biotech Announces Appointment of Kevin L. Lorenz, J.D., to Board of Directors
19/08/2019
NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019
19/08/2019
Revised time for Conference Call to be held August 19, 2019, at 5:30pm Eastern Time MINNEAPOLIS, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc., (NASDAQ: POAI) (“Predictive Oncology ” or “the Company”) an [...]
OraSure Announces Sale of Cryosurgical Systems Business
19/08/2019
BETHLEHEM, Pa., Aug. 19, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced the sale of its cryosurgical [...]
Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide Licence and Co-Devlopent of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19/08/2019
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma ( OTCPK : ONPH) is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ) for a world-wide [...]
Protech Home Medical Reports Solid Third Quarter Fiscal 2019 Financial Results
19/08/2019
Posts Revenue Growth of 7.1% and Adjusted EBITDA Growth of 7.8% NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED [...]
Kiniksa to Present Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
19/08/2019
HAMILTON, Bermuda, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]
Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of Postoperative Recovery Following Primary Hip or Knee Arthroplasty
19/08/2019
SAN CARLOS, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced the dosing of [...]

Pages